Search for a command to run...
ImmunityBio, Inc.
Biotechnology
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2026 | Lisa McClainR | Stock | Buy |
| $1,001 - $15,000 |
| $9.44 |
| $8.29 |
| -12.2% |
| -11.3% |
Sep 28, 2026 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $8.52 | $8.81 | +3.4% | +2.5% |
IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick
ImmunityBio Stock Jumps: What's Going On?
SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
IBRX Breaks Above This Key Resistance — Stock On Track To Record Best Single-Day Gains In 6 Months
A $5.8B Cancer Market Opportunity Is Emerging — Why GA-Courtenay Favors ImmunityBio (IBRX)